Chinese Drug Developer I-Mab Biopharma Files for U.S. IPO

I-Mab Biopharma Co., a Chinese language drug developer, has filed confidentially for a U.S. preliminary public offering because the firm works on a interior most fundraising, …
Read More

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button